Predictions
Schaeffler AG
Start price
Target price
Perf. (%)
€5.77
09.10.20
09.10.20
€6.50
28.10.20
28.10.20
-11.54%
28.10.20
28.10.20
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Kandi Technologies Corp.
Start price
Target price
Perf. (%)
€6.29
09.10.20
09.10.20
€7.70
28.10.20
28.10.20
-12.08%
28.10.20
28.10.20
EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
VivoPower International PLC
Start price
Target price
Perf. (%)
€18.60
09.10.20
09.10.20
-
04.11.21
04.11.21
-76.34%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
High valuation
International Business Machines Corp
Start price
Target price
Perf. (%)
€109.20
09.10.20
09.10.20
€129.00
28.10.20
28.10.20
-17.40%
28.10.20
28.10.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
International Business Machines Corp
Start price
Target price
Perf. (%)
€109.20
09.10.20
09.10.20
€129.00
28.10.20
28.10.20
-17.40%
28.10.20
28.10.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
SGL Carbon SE
Start price
Target price
Perf. (%)
€3.17
09.10.20
09.10.20
€8.00
04.11.21
04.11.21
165.09%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Lyondellbasell Ind. A
Start price
Target price
Perf. (%)
€66.42
09.10.20
09.10.20
€95.00
04.11.21
04.11.21
19.60%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€7.10
07.10.20
07.10.20
€3.00
04.11.21
04.11.21
-38.41%
05.11.21
05.11.21
Probably not worthwhile Investment
Little innovation
McPhy Energy S.A.
Start price
Target price
Perf. (%)
€24.70
06.10.20
06.10.20
-
04.11.21
04.11.21
21.05%
12.12.20
12.12.20
Business model of the past or high risk
Higher risks for its business
AT&T Inc..
Start price
Target price
Perf. (%)
€24.40
06.10.20
06.10.20
€30.00
04.11.21
04.11.21
-11.72%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Revenue growth >5% per year expected
EBIT growth >5% per year expected
PDL BioPharma Inc.
Start price
Target price
Perf. (%)
€2.11
06.10.20
06.10.20
-
04.11.21
04.11.21
5.22%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
High dividend yield expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
QuidelOrtho Corp.
Start price
Target price
Perf. (%)
€212.00
06.10.20
06.10.20
-
04.11.21
04.11.21
-44.10%
05.11.21
05.11.21
Innovative
Higher risks for its business